ResMed's first-quarter result broadly met market expectations, though rising margins and potential for further capital ...
Tariffs on medical devices would push up prices and disrupt research and development efforts at the expense of US patients, ...
Let's see which shares analysts are tipping as buys this month. The post Where to invest $10,000 in ASX shares in November ...
ResMed Inc. closed 16.14% below its 52-week high of $293.81, which the company reached on August 22nd.
TipRanks on MSN
ResMed CFO Reports Stock Transactions Under Rule 10b5-1 Plan
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( ($AU:RMD) ) has shared an update. ResMed Inc.’s Chief Financial Officer, ...
Using different oximeter devices for monitoring stable patients under NIV or CPAP may have an unpredictable effect on results and clinical decisions.
The Active Humidifier Devices Market is at a pivotal juncture, influenced by a blend of growth drivers, emerging trends, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback